InsiderTrades

Form 4 for PCVX Vaxcyte, Inc.

Accepted 2023-12-27 00:00:00 ET · period of report 2023-12-22 · accession 0001209191-23-059791 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2023-12-27 2023-12-22+ PCVX PICKERING GRANT CEO, Dir M - OptEx $1.03 +19.9K 390.8K +5% +$20.5K
DM 2023-12-27 2023-12-26 PCVX PICKERING GRANT CEO, Dir S - Sale+OE $61.70 -15.0K 383.4K -4% -$925.5K
DM 2023-12-27 2023-12-22+ PCVX PICKERING GRANT CEO, Dir M - OptEx $0.00 -19.9K 3,663 -84% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-12-22 M A 9,900 $2.03 380,814 D — —
2 Common Common Stock 2023-12-26 S D 7,550 $62.08 375,814 D — — (F3) The price reported is a weighted-average price. The shares were sold at prices ranging from $61.96 to $62.17. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
3 Common Common Stock 2023-12-26 S D 7,450 $61.32 383,364 D — — (F2) The price reported is a weighted-average price. The shares were sold at prices ranging from $60.885 to $61.76. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
4 Common Common Stock 2023-12-26 M A 10,000 $0.04 390,814 D — —
5 Derivative Stock Option (right to buy) 2023-12-22 M D 9,900 $0.00 292,327 D $2.03 · — to 2028-07-23 9,900 Common Stock (F6) Stock Option is fully vested and exercisable.
6 Derivative Stock Option (right to buy) 2023-12-26 M D 10,000 $0.00 3,663 D $0.04 · — to 2025-04-23 10,000 Common Stock (F6) Stock Option is fully vested and exercisable.